Australian Federation of AIDS Organisations (AFAO), 23 August, 2016 Following the Pharmaceutical Benefits Advisory Committee (PBAC) decision not to recommend funding PrEP through the Pharmaceutical Benifits Scheme (PBS), AFAO has produced an Australian PrEP roundup paper to sustain advocacy efforts and to raise awareness about current options for accessing PrEP around the country. In releasing...
ABC News, 27/04/16, 5:12pm
A groundbreaking new drug tipped to stop the spread of HIV within just a few years will be available to more than 2,000 Queensland men under a $6 million trial program.
The trials make Pre-Exposure Prophylaxis (PrEP) available to men who have sex with men, as a means of preventing HIV transmission.
Read more here